Cargando…

Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world’s leading cause of disability, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vilella, Antonietta, Ruozi, Barbara, Belletti, Daniela, Pederzoli, Francesca, Galliani, Marianna, Semeghini, Valentina, Forni, Flavio, Zoli, Michele, Vandelli, Maria Angela, Tosi, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491652/ https://www.ncbi.nlm.nih.gov/pubmed/26102358 http://dx.doi.org/10.3390/pharmaceutics7020074

Ejemplares similares

PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study
por: Hoyos-Ceballos, Gina P., et al.
Publicado: (2020)

Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
por: Pederzoli, Francesca, et al.
Publicado: (2019)

AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study
por: Ruozi, Barbara, et al.
Publicado: (2011)

Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders
por: Salvalaio, Marika, et al.
Publicado: (2016)

Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications
por: Duskey, Jason Thomas, et al.
Publicado: (2020)

Tunneling Nanotubes: A New Target for Nanomedicine?
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles
por: Rigon, Laura, et al.
Publicado: (2019)

Microfluidic Technology for the Production of Hybrid Nanomedicines
por: Ottonelli, Ilaria, et al.
Publicado: (2021)

Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
por: Rinaldi, Arianna, et al.
Publicado: (2022)

Tween(®) Preserves Enzyme Activity and Stability in PLGA Nanoparticles
por: Duskey, Jason Thomas, et al.
Publicado: (2021)

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
por: Duskey, Jason Thomas, et al.
Publicado: (2022)

Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy
por: Wang, Xiaowei, et al.
Publicado: (2020)

Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
por: El-Hammadi, Mazen M., et al.
Publicado: (2022)

Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
por: Sousa de Almeida, Mauro, et al.
Publicado: (2021)

Development of Novel Zn(2+) Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro Evidences
por: Grabrucker, Andreas M., et al.
Publicado: (2011)

Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy
por: Pascolo, Lorella, et al.
Publicado: (2014)

Quantitative comparison of the protein corona of nanoparticles with different matrices
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136]
por: Ottonelli, Ilaria, et al.
Publicado: (2023)

Synthesis of glycopeptides and glycopeptide conjugates
por: Doelman, Ward, et al.
Publicado: (2022)

Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors
por: Zoli, Michele, et al.
Publicado: (2018)

PLGA-loaded nanomedicines in melanoma treatment: Future prospect for efficient drug delivery
por: Das, Sreemanti, et al.
Publicado: (2016)

PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases
por: Alsaab, Hashem O., et al.
Publicado: (2022)

Industrial Scale Manufacturing and Downstream Processing of PLGA-Based Nanomedicines Suitable for Fully Continuous Operation
por: Operti, Maria Camilla, et al.
Publicado: (2022)

Glycopeptide antibiotics /
Publicado: (1994)

Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice
por: Vilella, Antonietta, et al.
Publicado: (2023)

Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
por: Valenza, Marta, et al.
Publicado: (2015)

Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment
por: Oddone, Natalia, et al.
Publicado: (2020)

Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine
por: Susa, Francesca, et al.
Publicado: (2019)

Recent trends in nanomedicine and tissue engineering
por: Thomas, Jince, et al.
Publicado: (2018)

Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines
por: Albalawi, Fahad, et al.
Publicado: (2021)

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)

Antifreeze glycopeptide diastereomers
por: Nagel, Lilly, et al.
Publicado: (2012)

Developments in Glycopeptide Antibiotics
por: Blaskovich, Mark A. T., et al.
Publicado: (2018)

Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine
por: Xie, M, et al.
Publicado: (2013)

Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice
por: Daini, Eleonora, et al.
Publicado: (2023)

Glycopeptide Hypersensitivity and Adverse Reactions
por: Huang, Vanthida, et al.
Publicado: (2020)

False-Positive Glycopeptide Identification via In-FAIMS Fragmentation
por: Rangel-Angarita, Valentina, et al.
Publicado: (2023)

Engineering caveolin-mediated endocytosis in Saccharomyces cerevisiae
por: Zhang, Qian, et al.
Publicado: (2022)

Advanced targeted nanomedicine: a communication engineering solution
por: Chude-Okonkwo, Uche, et al.
Publicado: (2019)

Engineering Tumor-Targeting Nanoparticles as Vehicles for Precision Nanomedicine
por: Gonda, Amber, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tijb0r11lcmg77isvjp1e5ghg3